Non-cancer medications for patients with incurable cancer: time to stop and think?
作者信息
Hall Peter S, Lord Simon R, El-Laboudi Ahmed, Seymour Matthew T
出版信息
Br J Gen Pract. 2010 Apr;60(573):243-4. doi: 10.3399/bjgp10X483887.
Abstract
摘要
相似文献
1
Non-cancer medications for patients with incurable cancer: time to stop and think?
Br J Gen Pract. 2010 Apr;60(573):243-4. doi: 10.3399/bjgp10X483887.
2
Planning palliative or terminal care: the dilemma of doctors' prognoses in terminally ill cancer patients.
Ann Oncol. 2002 Aug;13(8):1320-2; author reply 1322-3. doi: 10.1093/annonc/mdf223.
3
Uncommon underlying etiologies of reversible delirium in terminally ill cancer patients.
J Pain Symptom Manage. 2006 Sep;32(3):205-7. doi: 10.1016/j.jpainsymman.2006.05.005.
4
[Most of the terminally ill patients want to die at home. Advanced home care services can often replace palliative hospital care].
Lakartidningen. 2002 Feb 21;99(8):742-3, 746.
5
Antibiotics in palliative care: less can be more. .
BMJ Support Palliat Care. 2018 Jun;8(2):187-188. doi: 10.1136/bmjspcare-2017-001473. Epub 2018 Mar 2.
6
A practical approach to symptom management in palliative care.
Br J Hosp Med (Lond). 2006 Aug;67(8):404-8. doi: 10.12968/hmed.2006.67.8.21957.
7
Preserving life at the end of life: shifting the temporal dimension of hope.
Palliat Support Care. 2008 Jun;6(2):187-8. doi: 10.1017/S147895150800028X.
8
Taking oral histories to improve end-of-life care.
Nurs Times. 2015;111(3):21.
9
Palliative sedation therapy.
Br J Hosp Med (Lond). 2009 Apr;70(4):208-11. doi: 10.12968/hmed.2009.70.4.41623.
10
Lidocaine intoxication at very small doses in terminally ill cancer patients.
J Pain Symptom Manage. 2005 Jul;30(1):6-7. doi: 10.1016/j.jpainsymman.2005.05.005.
引用本文的文献
1
Negative impact of corticosteroid use on outcome in patients with advanced BTCs treated with cisplatin, gemcitabine, and durvalumab: A large real-life worldwide population.
Int J Cancer. 2025 Nov 15;157(10):2092-2102. doi: 10.1002/ijc.70009. Epub 2025 Jul 11.
2
Patterns of statin initiation and continuation in patients with breast or colorectal cancer, towards end-of-life.
Support Care Cancer. 2017 May;25(5):1629-1637. doi: 10.1007/s00520-017-3576-0. Epub 2017 Jan 18.
3
Inappropriate prescribing in patients accessing specialist palliative day care services.
Int J Clin Pharm. 2014 Jun;36(3):535-43. doi: 10.1007/s11096-014-9932-y.
4
Discontinuation of statin therapy in older people: does a cancer diagnosis make a difference? An observational cohort study using data linkage.
BMJ Open. 2012 May 21;2(3). doi: 10.1136/bmjopen-2012-000880. Print 2012.
本文引用的文献
1
Management and survival trends in advanced colorectal cancer.
Clin Oncol (R Coll Radiol). 2008 Oct;20(8):626-30. doi: 10.1016/j.clon.2008.04.014. Epub 2008 Jun 3.
2
Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial.
Lancet. 2008 May 31;371(9627):1839-47. doi: 10.1016/S0140-6736(08)60601-7. Epub 2008 May 12.
3
A meta-analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment: impact on survival and bleeding complications.
Cancer. 2007 Sep 1;110(5):1149-61. doi: 10.1002/cncr.22892.
4
Mortality from major cancer sites in the European Union, 1955-1998.
Ann Oncol. 2003 Mar;14(3):490-5. doi: 10.1093/annonc/mdg110.
5
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.
N Engl J Med. 2002 Jan 10;346(2):92-8. doi: 10.1056/NEJMoa011954.
6
Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease.
Arch Intern Med. 1993 Mar 8;153(5):578-81.
7
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.
N Engl J Med. 1995 Nov 16;333(20):1301-7. doi: 10.1056/NEJM199511163332001.
Zotero 插件